Description

Ovalbumin (OVA) is a member of the serpin superfamily and the predominant glycoprotein found in egg whites. It is a commonly used antigen for immunization and biochemical studies and is an established model allergen for airway hyper-responsiveness.

This mRNA is capped using CleanCap, TriLink's proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA.

TriLink offers both unmodified and 5-methoxyuridine modified OVA mRNA. Exogenous unmodified mRNA activates the innate immune system and production of cytokines, which will influence the overall induced immune response. mRNA modified with 5-methoxyuridine reduces this effect.

Product Details

Catalog NoL-7210

PurityPasses Agarose Gel Mobility

Length1437 nucleotides

Base CompositionFully substituted with 5-Methoxy-U

Concentration1.0 mg/mL

Buffer1 mM Sodium Citrate pH 6.4

Conversion Factor40 µg/OD260

Recommended StorageAt or below -40°C

ApplicationVaccine Development

Other Name(s)CleanCap®Ovalbumin mRNA (5-methoxyuridine)